is it legal to compound tirzepatide Compounded Tirzepatide: & Safe 2026 FDA Clarifies Compounding Rules as

Many people notice they feel hungry sooner after meals and have less of the early fullness that made smaller portions feel easier

Reuters reports that Eli Lilly expects approval for its oral obesity drug in March 2026

First, it will be most effective for overweight people, patients with diabetes, as well as all people who would like to improve their health

Planning the safest timing to start or stop GLP-1 therapy

Borensztein is a triple board-certified endocrinologist and obesity specialist with same-week appointments available in Collingswood, NJ Have questions about getting started, managing side effects, or figuring out which medication is right for you

It's important to note that GLP-1 receptor agonists are not indicated for type 1 diabetes or for the treatment of diabetic ketoacidosis